Related references
Note: Only part of the references are listed.Dactinomycin and Vincristine Toxicity in the Treatment of Childhood Cancer: A Retrospective Study From the Children's Oncology Group
Bryan Langholz et al.
PEDIATRIC BLOOD & CANCER (2011)
Clinical Pharmacology in the Adolescent Oncology Patient
Gareth J. Veal et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
J. S. McCune et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood
Kenneth K. Khamly et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
Linda Granowetter et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
Iyad Sultan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
Carola A. S. Arndt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults
Tobias M. Dantonello et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Population Pharmacokinetics of Cyclophosphamide and Metabolites in Children With Neuroblastoma: A Report From the Children's Oncology Group
Jeannine S. McCune et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Challenges of mucositis assessment in children: Expert opinion
Deborah Tomlinson et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2008)
The distinctive biology of cancer in adolescents and young adults
Archie Bleyer et al.
NATURE REVIEWS CANCER (2008)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
Measurement of oral mucositis in children: a review of the literature
Deborah Tomlinson et al.
SUPPORTIVE CARE IN CANCER (2007)
Young adult oncology: The patients and their survival challenges
Archie Bleyer
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: Pharmacokinetics, liver toxicity, and mortality
Jeannine S. McCune et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-EWING 99 clinical trial
Christine Juergens et al.
PEDIATRIC BLOOD & CANCER (2006)
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: An analysis from the German Hodgkin Study Group
B Klimm et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: Experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee
D Orbach et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: Third study of the International Society of Paediatric Oncology - SIOP malignant mesenchymal tumor 89
MCG Stevens et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical pharmacokinetics of cyclophosphamide
ME de Jonge et al.
CLINICAL PHARMACOKINETICS (2005)
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group
SL Spunt et al.
CLINICAL CANCER RESEARCH (2004)
Age is an independent prognostic factor in rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
D Joshi et al.
PEDIATRIC BLOOD & CANCER (2004)
Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide
C Arndt et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - A report from the IRSG
SS Donaldson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease
WM Crist et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV
KS Baker et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
